Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search


Pacific Edge named Top Bioscience Company in 2014

Pacific Edge named Top Bioscience Company in 2014

Pacific Edge has been named NZBIO’s top bioscience company for 2014. Pacific Edge was specifically recognised for building the profile and credibility of biotechnology and biotechnology companies in New Zealand.

The announcement of the industry accolade this week is further recognition for the Dunedin based cancer diagnostic company and comes a few months after taking the Supreme Award at the NZ Innovation Council Awards.

Pacific Edge Chief Executive Office David Darling says the Company is delighted to receive the recognition for the advances being made to the clinical capability for the detection and management of cancers. The company’s Urine Sampling System is becoming a core element of the advances in clinical utility, which can be used by the patient in-home to take a sample.

“It is rare in the biotechnology sector to have a company with the capability and resources to go from discovery science all the way through clinical trials and product development to finally making a commercial product as Pacific Edge has done with Cxbladder – our molecular diagnostic test for bladder cancer.”

Cxbladder is a non-invasive test with the Company’s easy to use Urine Sampling System becoming a core element of the advances in clinical utility, which allows patients can use at home. The sample is analysed in one of Pacific Edge’s laboratories for the tell-tale molecular markers that will provide the urologist with information on the probability of the patient having bladder cancer, or not.

Cxbladder is now available commercially in the United States through the company’s own CLIA and CAP regulated laboratory in Hershey, Pennsylvania. In the later part of 2013 the company signed three large, preferred national provider networks. These provider networks provide patients access to healthcare services and technology by contracting with providers and payers on a national basis. These three agreements signed with FedMed, ACPN and Stratose give millions of Americans access to Cxbladder and its positive benefits as a quick, cost effective, non-invasive and highly accurate cancer detection test that is particularly appealing to US healthcare professionals, patients, and insurers.

The custom built, commercial laboratory for Pacific Edge’s US subsidiary PEDUSA was completed in September 2012 to process Cxbladder samples, was certified in 2013 by CLIA and more recently by CAP, to enable the laboratory to offer Cxbladder as a Laboratory Developed Test (LDT) to clinicians and physicians.


© Scoop Media

Business Headlines | Sci-Tech Headlines


Welcome Home: Record High Migration Stokes 41-Year High Population Growth

New Zealand annual net migration hit a new high in October as more people arrived from than departed for Australia for the first time in more than 20 years. More>>


Citizens' Advice Bureau: Report Shows Desperate Housing Situation Throughout NZ

CAB's in-depth analysis of over 2000 client enquiries about emergency accommodation shows vulnerable families, pregnant women and children living in cars and garages, even after seeking assistance from the Ministry of Social Development and Housing New Zealand. More>>


Speaking For The Bees: Greens Call For Neonicotinoid Pesticide Ban

The National Government should ban the use of controversial pesticides called neonicotinoids after evidence has revealed that even at low doses they cause harm to bee populations, the Green Party said today. More>>


Science Awards: NZAS Celebrate NZ Scientific Achievements

The Marsden Medal is awarded for a lifetime of outstanding service to the cause or profession of science, in recognition of service rendered to the cause or profession of science in the widest connotation of the phrase. This year’s medal is awarded to Dr Mike Andrews. More>>


Court Rules: Affco 'Unlawfully' Locked Out Meat Workers

The note says the full court found for the plaintiffs, "that is that the defendant locked out the second plaintiffs unlawfully and that it breached s 32 of the Act by acting otherwise than in good faith towards the plaintiffs while collective bargaining was still going on." More>>


New Bill Introduced: GST On Online Services

These measures are an important first step in the Government’s efforts to deal with increasing volumes of online services and other intangibles purchased from overseas suppliers that should, under New Zealand’s tax rules, be subject to GST. More>>


Get More From Scoop

Search Scoop  
Powered by Vodafone
NZ independent news